Department of Cardiac Surgery, Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Department of Radiology, Medical Imaging Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
PLoS One. 2022 Oct 12;17(10):e0275563. doi: 10.1371/journal.pone.0275563. eCollection 2022.
Chronic lung allograft dysfunction (CLAD), subclassified into bronchiolitis obliterans syndrome (BOS) or restrictive allograft syndrome (RAS), limits survival after lung transplantation. Information concerning transition from BOS to RAS is limited. We aimed to characterize the lung volume change after BOS diagnosis by computed tomography (CT) volumetry and to determine the incidence, risk factors and clinical significance of BOS to RAS transition.
CT volumetry measurements were performed from 63 patients with CLAD initially classified as BOS by CT volumetry. BOS patients with lung volume remaining >85% of baseline were classified as persistent BOS, whereas BOS patients whose lung volume permanently decreased to ≤85% of baseline were classified as BOS to RAS transition.
During follow-up (median 9.8 years) eight patients (12.7%) were classified as BOS to RAS transition, which decreased recipient (p = 0.004) and graft survival (p = 0.020) in comparison to patients with persistent BOS. Opacities on chest imaging preceded BOS to RAS transition in 88% of patients. Opacities on chest imaging at BOS diagnosis and early CLAD diagnosis after transplantation were risk factors for transition.
Based on lung volume decrease measured by CT volumetry, a small proportion of BOS patients transitioned to RAS which had an adverse effect on recipient and graft survival.
慢性肺移植功能障碍(CLAD),分为闭塞性细支气管炎综合征(BOS)或限制性移植综合征(RAS),限制了肺移植后的生存。关于从 BOS 向 RAS 转变的信息有限。我们旨在通过 CT 体层摄影术(CT)体积测量来描述 BOS 诊断后的肺容积变化,并确定 BOS 向 RAS 转变的发生率、危险因素和临床意义。
对 63 例 CLAD 患者进行 CT 体积测量,这些患者最初通过 CT 体积测量被分类为 BOS。将肺容积保持在基线的>85%的 BOS 患者分类为持续 BOS,而肺容积永久降至基线的≤85%的 BOS 患者分类为 BOS 向 RAS 转变。
在随访期间(中位数为 9.8 年),8 例(12.7%)患者被归类为 BOS 向 RAS 转变,与持续 BOS 患者相比,受者(p=0.004)和移植物存活率(p=0.020)降低。88%的患者在 BOS 向 RAS 转变前有胸部影像学上的混浊。胸部影像学上的混浊在 BOS 诊断和移植后早期 CLAD 诊断时是转变的危险因素。
基于 CT 体层摄影术测量的肺容积减少,一小部分 BOS 患者向 RAS 转变,这对受者和移植物的存活有不利影响。